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Abstract
We have generated transgenic mice expressing the amino-terminal fragment of the
phosphatidylinositol 3-kinase (PI3K) catalytic subunit (p110ABD) in thymocytes. Expression of
p110ABD results in constitutive activation of PI3K and in significant increases in the numbers of
mature, single-positive thymocytes. We previously reported that the increase in mature cells was
in part due to a defect in thymic emigration. In this study we identify another component to this
phenotype. Expression of p110ABD results in an enhancement of positive selection, without alterations
in thymocyte lifespan or negative selection. Since PI3K can affect activation of Btk, which in turn
potentiates calcium fluxes, during B cell development, our results suggest that PI3K could play a role
in the regulation of Itk kinases in T cells, and that both cell types share a common signaling network
to modulate calcium responses downstream of their antigen receptor.
Introduction
During T cell development, the organism generates a T cell
population with an extended repertoire of antigen specificities.
This repertoire is molded in the thymus through signals
derived from the interaction of TCRs on thymocytes with their
ligands, MHC molecules with bound peptides. The majority of
thymocytes bear TCRs that do not recognize the MHC
molecules present in the thymus, and these cells die relatively
rapidly (3–4 days). Those cells bearing a TCR able to interact
with self-MHC can receive signals that induce either their
differentiation into mature T cells (positive selection) or apop-
tosis (negative selection). Furthermore, those cells that are
positively selected develop into two different lineages, CD4 or
CD8, depending on the ability of their TCRs to bind MHC class
II or I, respectively. Most of what we understand about these
processes has been learnt using genetically modified mice,
especially mice engineered to express a re-arranged trans-
genic TCR (Tg TCR). The majority of double-positive (DP)
thymocytes in these mice express the same TCR, which can be
detected with specific antibodies, and therefore behave as
a relatively homogeneous population. Breeding Tg TCR mice
with mice with alterations in different signaling molecules has
provided most of our current knowledge regarding the role of
different signal transduction pathways in the regulation of the
different cell fate decisions during T cell development.
One of the pathways important for both positive and
negative selection in the thymus is TCR-mediated Ca++ fluxes.
Ca++-dependent events, such as transcription of the Nur-77
family of transcription factors, appear to be critical for negative
selection: expression of a dominant negative Nur77 transgene
in Tg TCR+ thymocytes inhibits antigen-dependent negative
selection (1). However, over-expression in the thymus of low
levels of constitutively active calcineurin, a calcium-regulated
phosphatase, does not alter negative selection (2), although
calcineurin plays an important role in the transcriptional regu-
lation of Nur77 (3, 4). Calcineurin activation instead improves
positive selection (2). Therefore, subtle alteration in Ca++
responses may have a bigger impact on positive selection.
TCR-induced Ca++ influx in thymocytes can be regulated
by Tec family kinases (5, 6). These tyrosine kinases contain
N-terminal pleckstrin homology (PH) domains that allow
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regulation of the kinase by Class I phosphatidylinositol 3-
kinases (PI3Ks). Class IA PI3Ks consist of catalytic subunits
that interact with SH2 domain-bearing adaptor subunits,
whereas the Class IB PI3K p110c utilizes a p101 adaptor
subunit and is stimulated by G-protein bc subunits. While
multiple Class IA subunits have been implicated in T lympho-
cyte signaling, the p85a and p110a subunits are thought to
largely mediate PI3K function in T cells.
We have previously described mice expressing the gain-
of-function thymocyte-specific transgene p110ABD, which
induces constitutive Akt activity and potentiates TCR-induced
Ca+2 influx. We observed an accumulation of mature, CD3hi
single-positive (SP) thymocytes in p110ABD mice, and de-
scribed that this phenotype was in part due to a delay in the
exit of mature thymocytes to the periphery (7). Here we show
that the increase in mature T cells in the thymus is also partly
due to a specific improvement in positive selection. On the
other hand, basal DP survival and negative selection are un-
affected by p110ABD expression.
Methods
Generation of p110ABD transgenic mice
The p110ABD construct, consisting of amino acids 1 through
109 of p110a, was obtained from Julian Downward (ICRF,
London, United Kingdom). The construct was cloned into the
BamHI site of the p1017 vector (8), and the NotI fragment
purified and injected into (C57Bl/6 3 DBA/2J)F1 zygote
pronuclei. Founder mice were identified by Southern blotting
of genomic DNA probed with a human growth hormone
fragment and subsequently backcrossed with C57Bl/6 mice
(Jackson Laboratories, Bar Harbor, ME, USA). Subsequent
progenies were genotyped by dot blot using the hGH probe or
by PCR with hGH-specific primers. OT-I, HY and AND trans-
genic animals were all obtained from Jackson Laboratories.
Erksem mice were the kind gift of Stephen M. Hedrick (UCSD).
Flow cytometry
Bcl-2 intracellular staining was performed with the Cytofix/
Cytoperm kit (BD PharMingen, cat. no. 2075KK). Briefly,
freshly isolated thymocytes (2 3 106) were suspended in 200
ll Cytofix/Cytoperm and incubated on ice for 30 min. After
washing with PBS containing 1% FCS and 0.01% Na-Azide,
cells were re-suspended in 80 ll Perm/Wash and 20 ll anti-Bcl-
2–FITC or isotype-matched control antibody (BD PharMingen,
cat. no. 1502KK). Cells were incubated on ice 30 min, then
washed twice with Perm/Wash and re-suspended in PBS/FCS/
azide for the analysis.
All surface antibodies were obtained from BD PharMingen
or eBioscience (San Diego, CA, USA) and were used in-
terchangeably. Analyses were performed using a Beckton-
Dickinson FACSCalibur or a Beckton-Dickinson FACScan.
Analysis of flow cytometry data was performed using FlowJo
(TreeStar Software, Ashland, OR, USA).
In vitro survival assays
In a 96-well plate, 106 thymocytes were aliquoted per well. For
antigen-independent assays, each well was re-suspended
in 100 ll of DMEM complete with 10% FCS and b-
mercaptoethanol (ME). Plates were incubated at 37C in 5%
CO2 for varying times and then analyzed by flow cytometry.
Viable DP thymocytes were determined by forward and side
scatter. For dexamethasone sensitivity assays, each well was
re-suspended in 100 ll DMEM complete/FCS/b-ME containing
0, 109, 108, 107 or 106 M dexamethasone (Sigma D1756).
Plates were incubated for 12 h and then analyzed by flow
cytometry. Viable DP thymocytes were determined by forward
and side scatter or Annexin V staining. Both methods gave
identical results when tested in parallel.
5-Bromo-2-deoxyuridine-labeling experiments
5-Bromo-2-deoxyuridine (BrdU) (Sigma, B5002) was either
provided continuously in drinking water at 0.8 mg ml1 until
analysis or, for pulse-chase analysis of SP differentiation in
AND H-2b/d animals, was administered in two intraperitoneal
injections, each 1 mg in 200 ll PBS, 3-h apart. BrdU staining
was performed in duplicate as follows: cells were stained
for surface antigens, washed with PBS and re-suspended in
500 ll of 0.15 M NaCl. Ninety-five percent EtOH (1.2 ml) at
20C was added dropwise, and the cells were incubated for
30 min on ice. Following a wash with PBS, the cells were
re-suspended in 1 ml of 1% PFA/0.01% Tween 20 in PBS and
incubated overnight at 4C. The cells were then centrifuged
and directly re-suspended in 1 ml of DNase I solution (50
Kunitz units ml1 in 0.15 M NaCl, 4.2 mM MgCl2, 10 lM HCl;
Sigma D4527). After incubation for 30 min at 37C, the
samples were washed and stained with FITC anti-BrdU
or isotype control antibody (BD PharMingen).
OT-I deletion assays
In vitro deletion assays were performed as described (9). EL4
cells were irradiated with 3000 R and plated at 53 104 per well
in round bottom 96-well plates. The SIINFEKL peptide was
diluted in DMEM and added to varying concentrations ranging
from 107 to 1013 M. Duplicate samples of 106 OT-I or OT-I
p110ABD thymocytes were added per well to a final volume of
200 ll and incubated for 18 h at 37C. Samples were then
analyzed by flow cytometry as described for survival assays
above.
Results
Phenotype of p110ABD transgenic mice
We have described the generation of the p110ABD transgenic
mice elsewhere (7). Briefly, the transgene consists of the
adaptor-binding domain from the p110a subunit, and its
expression is directed to thymocytes by the lck proximal
promoter. Expression of this transgene competes with wild-
type p110 for the adaptors, and results in constitutive acti-
vation of p110, as evidenced by constitutive activation of Akt
in resting p110ABD thymocytes, and by an improvement in the
ability of thymocytes to achieve maximal Ca++ influx in re-
sponse to sub-optimal concentrations of anti-CD3 antibody (7).
p110ABD mice display a distinctive phenotype: the fraction
and numbers of mature thymocyte subsets are nearly doubled
in transgenic animals compared with wild type. Figure 1 shows
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representative examples of transgenic and NLC thymi from
one of the four lines of mice generated and demonstrates that
both SP compartments as well as the CD3hi fraction are
increased by p110ABD expression. All four lines exhibit similar
phenotypes, and except where indicated, are used inter-
changeably throughout this work. We observe a slight, con-
comitant decrease in the CD4+CD8+ DP compartment, but
the percentage of CD4CD8 double-negative (DN) cells is
unchanged. When we examined the DN compartment more
closely, we could not find any significant changes in the
distribution among the DN sub-populations DN1 through DN4
in p110ABD transgenic mice. Also, we did not observe any
p110ABD-induced change in the numbers of cdTCR+ thymo-
cytes (data not shown). Both abT cell lineages are similarly
affected, as shown by the similar CD4:CD8 ratios observed in
the CD3hi compartment of both NLC and p110ABD mice. For
the thymi depicted in Fig. 1, these ratios are 2.91 versus 2.51,
respectively. As we described previously (7), the SP popula-
tions are enriched for cells that are more mature and express
low levels of HSA.
p110ABD transgenic animals display a normal peripheral
phenotype. NLC and p110ABD mice have similar numbers of
peripheral CD4 and CD8 abT cells and cdT cells in either
the spleen or mesenteric lymph nodes. Furthermore, no
transgene-induced differences are observed in the periphery
of old mice (6 and 9 months), indicating that there is no subtle,
accumulative effect. We also examined activation and memory
markers on peripheral T cells to see if altered thymocyte de-
velopment had perturbed peripheral functions. However, we
see no changes in the numbers of CD25+ CD69+-activated
T cells or CD44hi CD62Llo memory T cells (data not shown).
We have shown previously that p110ABD expression impairs
the exit of mature thymocytes into the periphery. However,
effects in the DP compartment could also contribute to the
observed phenotype. At the DP stage, PI3K could modulate
survival or selection. For example, p110ABD could improve DP
survival, making it easier for the developing cells to express
a good TCR and be positively selected. Alternatively, it could
specifically improve positively selecting signals, rescuing cells
whose TCR react with very low affinity with self-MHC+ peptide.
On the other hand, PI3K activity could inhibit negative
selection, allowing cells that would normally be deleted to
mature. All three options are suggested by previous work on
PI3K effectors in thymocytes. We therefore examined each
process individually to assess the role of PI3K in DP
thymocytes.
Possible survival functions of PI3K in DP thymocytes
DP thymocytes have ~3 days in which to receive positive
selection signals that induce survival and maturation. Since
one of the best-characterized consequences of PI3K-induced
Fig. 1. p110ABD expression increases the percentage of single-positive thymocytes, without altering the CD4/CD8 ratio. (A) Flow cytometric
analysis of thymocytes from 8-week old mice from p110ABD transgenic and NLC. Thymocytes were stained with CD8–FITC, CD4–PE and CD3–
allophycocyanin. Shown are CD4/CD8 two-color dot plots and a CD3 histogram. The percentage of cells in the different regions is indicated. The
percentages of cells in the CD3 high gate are represented as transgenic/control. (B) The CD3hi were gated, and their CD4/CD8 distribution
analyzed.
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signals in other systems is improved cell survival, we reasoned
that it may increase basal DP survival, allowing thymocytes
a longer window in which to receive selecting signals rather
than directly participating in the signal pathway of positive
selection itself.
Because of the loss of Bcl-2 expression, DP thymocytes may
die due to the lack of antigenic stimulation (death by neglect).
They are also extremely sensitive to physiological stress or
corticosteroid exposure. Akt activation can prevent apoptosis
in multiple cell types but a similar role for Akt in thymocytes has
remained controversial. Whereas both gagPKB and myrPKB
expression improved the viability of thymocytes treated with
dexamethasone, myrPKB had a negligible effect on survival in
the absense of stimulation (10, 11). We thus analyzed death
by neglect by culturing thymocytes in vitro without antigenic
stimulation and assessed cell survival over time. NLC and
p110ABD DP thymocytes died at the same rate in these assays
(Fig. 2A). We also observed identical apoptotic responses
when NLC and p110ABD DP thymocytes were cultured for 6 h
with dexamethasone over a range of concentrations (Fig. 2B).
Viable DP thymocytes were determined by forward and side
scatter or Annexin V staining. Both methods gave identical
results when tested in parallel.
Since the survival ability of thymocytes in vitro may not be
an accurate representation of that in vivo, we designed an
experiment to examine DP thymocyte lifespan in vivo. We
monitored the transit of thymocytes through the DP compart-
ment using BrdU. In young animals, the size of the DP
compartment remains constant through time; thus, cells will
exit the compartment (via death or differentiation) at the same
rate as they enter it by b-selection. By supplying animals with
BrdU (0.8 mg ml1) in their drinking water, we label thymocytes
in vivo during the proliferative burst that occurs at the DN to DP
transition. In normal animals, DP thymocytes typically survive
for 3 days; therefore, after 1 day of BrdU labeling, one-third of
the DP cells should be BrdU+ in wild-type animals. The DP
compartments of both p110ABD and NLC mice are completely
labeled at similar rates within 3–4 days (Fig. 2C), demonstrat-
ing that p110ABD and NLC DP thymocytes have comparable
lifespans.
These results were surprising since p110ABD thymocytes
have increased basal Akt activity (7), and there is evidence
that DP survival can be regulated by Bad and/or Bcl-XL via Akt.
Jones et al. (10) observed up-regulation of Bcl-XL in gagPKB
thymocytes that was presumably mediated by reduced
association with Bad (10). Furthermore, over-expression of
Bad in thymocytes greatly reduces the total number of
thymocytes and the percentages of SP thymocytes (12). But
in spite of elevated Akt activity, we did not observe changes in
Bad phosphorylation at Ser-136 or Bcl-XL levels in p110ABD
thymocytes. Also, resting p110ABD thymocytes did not exhibit
increased nuclear factor-jB (NF-jB) DNA-binding activity
compared with NLC, ruling out the up-regulation of survival
Fig. 2. p110ABD expression does not alter DP survival or lifespan.
(A) p110ABD DP thymocytes are as susceptible to ‘death by neglect’
as NLC. NLC and p110ABD thymocytes were cultured in vitro without
antigenic stimulation and survival assessed by flow cytometry. (B) NLC
and p110ABD SP thymocytes are equally susceptible to steroid-
induced apoptosis. Thymocytes were cultured with varying concen-
trations of dexamethasone for 12 h and then analyzed as in (A). Viable
DP thymocytes were determined by forward and side scatter or
Annexin V staining. Both methods gave identical results when tested in
parallel. (C) NLC and p110ABD DP thymocytes have the same lifespan.
Since thymocyte development exists in equilibrium, thymocytes enter
the DP compartment at the same rate as which they exit (via death or
development). Therefore, when BrdU is supplied in drinking water (at
0.8 mg ml1), thymocytes integrate BrdU as they become DP during
b-selection, and the average lifespan of a DP thymocyte is the time
required to completely label the compartment.
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genes controlled by this transcription factor (data not shown).
These results explain the lack of effect of p110ABD on thy-
mocyte survival, although we do not yet understand the com-
pensatory mechanisms that mediate the regulation of Bad in
these cells. However, DP survival is likewise unaffected by the
expression of the activating transgene p65PI3K (13), in agree-
ment with our results.
PI3K activity improves thymocyte positive selection in the
Tg TCR AND system
To study if the constitutive activation of PI3K effectors could
affect positive selection, we crossed the p110ABD transgenic
mice with mice bearing the Tg TCR AND. This system has
been used in the past to confirm the role of Erk in positive
selection (14). The AND TCR recognizes a fragment of pigeon
cytochrome C presented by I-Ek molecules. Thymocytes
expressing this MHC class II-restricted TCRs are positively
selected by I-Ab and I-Ek molecules but not I-Ad (15). Since the
p110ABD mice were generated on a C57Bl/6 background, they
are H-2b (I-Ab I-Eo). We bred two lines of p110ABD mice to AND
transgenic animals on a H-2d (I-Ad I-Ed) background to gen-
erate progeny with a partially selecting background, H-2b/d, in
which antigen-presenting cells (APCs) present a low amount
of I-Ab that induces sub-optimal positive selection (scored as
25% CD4 SP versus 50% in H-2b or 10% in H-2d) (15).
Expression of the p110ABD transgene significantly improves
the positive selection of AND-bearing CD4 thymocytes in H-
2b/d animals (Fig. 3A). The percentage of CD4 SP thymocytes
is increased from an average of 29.2% in AND H-2b/d mice to
41.6% in AND H-2b/d p110ABD animals from the p110ABD
19416 line (n = 21 and n = 24, respectively). Similarly, in
animals from line 15669, the CD4 SP fraction is increased from
21.8% (n = 18) to 32.5% (n = 16). As in non-TCR transgenic
mice, the HSAlo compartment is especially enriched in animals
expressing p110ABD. CD4 SP HSA
lo thymocytes account for
only 6.3% of the thymus in AND H-2b/d mice, but they
constitute 18.1% of the thymi of AND H-2b/d p110ABD mice
from line 19416. In line 15669-derived mice, the proportions
are 7.1% and 17.9%, respectively. The total numbers of
thymocytes are decreased in AND H-2b/d p110ABD animals
(19.7 6 6.9 3 107 versus 37.5 6 1.5 3 107), a phenomenon
that was also observed previously in AND H-2b/b Erksem
animals (14). Our results suggest that expression of p110ABD
dramatically improves AND CD4 SP selection in the H-2b/d
background, almost restoring the levels observed in an op-
timal selecting background, H-2b/b.
However, the higher percentages of CD4 SP thymocytes
observed in AND H-2b/d animals expressing p110ABD could
also be due to the delay in thymic exit we have previously
described in these mice (7). To specifically examine the short-
term generation of SP thymocytes in the AND H-2b/d back-
ground, we performed BrdU pulse-chase experiments. A
cohort of proliferating cells was labeled with BrdU by intra-
peritoneal injection and the thymi were analyzed by flow
cytometry 5 days later. The graph in Fig. 3(B) displays the
fraction of thymocyte sub-populations that were BrdU+ 5 days
after BrdU administration. The majority of proliferating thymo-
cytes are those undergoing b-selection into the DP compart-
ment, as described above. Since the average lifespan of a DP
thymocyte is 3 days, most of the BrdU+ cells would have left
the compartment by 5 days post-label, either by selection or
death by neglect. Both AND and AND p110ABD animals have
small numbers of BrdU+ DN and DP thymocytes after 5 days.
These cells are probably the progeny of early DN subsets that
have since differentiated or even newly arrived thymocyte
progenitors. However, a greater fraction of CD4 SP thymocytes
are BrdU+ in AND p110ABD mice compared with AND litter-
mates. This demonstrates that a greater fraction of the com-
partment is newly generated each day, indicating improved
positive selection. Increased SP proliferation does not account
for the higher fraction of BrdU+ cells, as p110ABD expression
does not increase SP division (data not shown). BrdU+ cells
likewise account for a greater fraction of the CD3hi HSAhi and
CD3hi HSAlo populations in p110ABD-expressing mice com-
pared with non-transgenic animals after 5 days. BrdU tracking
Fig. 3. p110ABD expression improves positive selection of AND Tg
TCR thymocytes. (A) The AND Tg TCR is positively selected by I-A
molecules but can not direct thymocyte development on I-A: CD4 SP
development is sub-optimal in the H-2b/d background. However, ex-
pression of p110ABD increased the number of CD4 SP thymocytes in
AND mice, indicating improved positive selection. (B) Five days
following a pulse labeling of DP thymocytes, more AND H-2 p110ABD
mature thymocytes are BrdU+ than AND H-2b/d alone. This reflects
more SP and CD3hi thymocytes differentiating from the pool of labeled
DP precursors. By contrast, if SP differentiated normally but accumu-
lated in p110ABD animals due to a delayed exit from the thymus, BrdU
+
cells would constitute a smaller fraction of SP subsets in AND p110ABD
than in AND. Mice were injected twice intra-peritoneally with 1 mg
BrdU, 3-h apart. At 5 days, the animals were sacrificed and cells
stained for analysis by flow cytometry.
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thus demonstrates that improved positive selection results in
greater BrdU labeling of all mature thymocyte subsets.
The effect of p110ABD on positive selection is lineage
independent
We observe no skewing of lineage choice in our p110ABD
animals. In a non-Tg TCR background, the CD8 SP population
is increased the same magnitude as the CD4 SP. As shown in
Fig. 1(B), the CD4:CD8 ratio of CD3hi thymocytes in NLC and
p110ABD mice was not significantly different: 2.91 versus 2.51,
respectively, in the animals shown. We have crossed the
p110ABD transgene onto three different Tg TCRs in total, two
class I-restricted (HY and OT-I) and one class II-restricted
(AND), and we have observed no change in lineage choices
(data not shown).
There are significant numbers of CD8 SP thymocytes in
all AND H-2b/d mice. Some of these are presumably the
‘intermediate’ CD8 SP (ISP), immature cells progressing from
the DN to DP compartments that up-regulate CD8 prior to
CD4. But most are CD3hi, indicating that they are mature cells
that have undergone positive selection. Since these animals
were Rag+/, these cells may have re-arranged endogenous
TCRa chains and been selected by these TCR. Or they may
simply be ‘mismatched’, in that co-receptor expression was
not correctly matched to the MHC specificity of the TCR, since
AND Rag2/ precursors can generate TCRhi CD8 SP pro-
geny (16). Interestingly, even though p110ABD expression
does not increase the percentage of CD8 SP in AND H-2b/d
animals, it does increase the BrdU+ fraction of this population
in the labeling experiments (Fig. 3A). The increase in BrdU+ SP
thymocytes was comparable between both lineages. This
suggests that p110ABD expression can improve the positive
selection of CD8 SP thymocytes even in a system biased to the
CD4 fate and argues against a selective role for PI3K in CD4
development only.
Importantly, neither do we observe an accumulation of CD4
SP thymocytes in OT-I p110ABD animals nor in female p110ABD
mice expressing the class I-restricted Tg TCR HY. We crossed
the OT-I Tg TCR onto two lines of p110ABD mice, 19415 and
15669, and found no significant differences in the CD4:CD8
ratio induced by p110ABD expression. It should also be noted
that the populations expressing high levels of the Tg TCR Va
chain, Va2, exhibit the same CD4:CD8 ratios as for total SP
thymocytes. Thus, p110ABD expression does not specifically
potentiate CD4 SP development in the class I-restricted Tg
TCR systems studied.
The roles of Ras and Erk in p110ABD-induced positive
selection
The increased positive selection in AND p110ABD animals
resembles that observed in AND transgenic animals express-
ing the Erk2 sevenmaker mutant (Erksem) (14). This mutant is
hypersensitive to activation rather than being constitutively
active. Intriguingly, Erk was shown to be inhibited in anti-CD3-
stimulated T cells treated with wortmannin (17, 18). PI3K-
mediated modulation of Erk activation was also suggested by
the impaired TCR-induced Erk phosphorylation that is ob-
served in p110dD910A mutant mice (19). Furthermore, Erk was
found to be constitutively phosphorylated in resting PTEN-
deficient peripheral T cells (20). We therefore considered the
possibility that the p110ABD transgene improves positive
selection by enhancing Erk activation.
Resting thymocytes from both NLC and p110ABD mice have
the same intracellular levels of phospho-Erk when measured
by flow cytometry (Fig. 4A), and both display the same sensi-
tivity to phorbol myristate acetate treatment. We also assessed
CD69 expression as a representation of the Erk activity in-
duced by CD3 cross-linking, since Ras activity is sufficient to
direct up-regulation of this marker (21). We performed a
checkerboard analysis in which thymocytes were stimulated
for 3, 9 and 18 h over a range of concentrations. Two analyses
of these experiments are shown in Fig. 4(B). There are no
detectable p110ABD-induced difference in the kinetics of
CD69 up-regulation or in the dose-response curve. Thus,
Fig. 4. p110ABD expression does not up-regulate Erk activity. (A) Phorbol myristate acetate (PMA) treatment induces identical Erk phosphoryl-
ation in NLC and p110ABD thymoyctes. Freshly isolated thymocytes were stimulated with varying concentrations of PMA for 10 min and analyzed by
flow cytometry. (B) CD69 expression serves as a surrogate marker for Erk activity in thymocytes and is up-regulated at the same rate in NLC
and p110ABD thymocytes. For the top graph, thymocytes were stimulated with plate-bound anti-CD3 (10 lg ml
1) and CD69 expression assessed
by flow cytometry at 3, 9 and 18 h. The bottom graph represents CD69 expression induced by anti-CD3 treatment for 9 h over a range
of concentrations.
926 PI3K and positive selection
although p110ABD can potentiate calcium flux responses, and
therefore the concomitant DAG production, this does not
significantly modify activation of the RasGRP/Ras/Erk pathway
in DP thymocytes. We therefore conclude that PI3K can
promote positive selection via an Erk-independent pathway.
Negative selection is unaffected in p110ABD animals
Impaired negative selection could also contribute to the ob-
served phenotype of p110ABD mice. We therefore examined
the potential effect of the p110ABD transgene in two model
systems. For one, we observed deletion of p110ABD thymo-
cytes in vivo by viral superantigens (vSAGs). All mouse strains
are endogenously infected with a variety of mouse mammary
tumor viruses (MMTVs) that express vSAGs ubiquitously.
vSAGs constitutively cross-link I-E molecules with specific
TCR Vb segments irrespective of the peptide bound by MHC.
This constitutes a strong TCR signal, inducing the deletion of
thymocytes bearing such segments (22). C57Bl/6 mice are
endogenously infected with MMTV 8 but do not express I-E,
and thus retain thymocytes utilizing the Vb segments rec-
ognized by vSAG8, Vb11 and 12. In addition to MMTV 8,
DBA/2J mice carry MMTV 7, and vSAG7 recognizes Vb6, 7,
8.1 and 9. We crossed the p110ABD mice on the C57BL/6
background (MMTV8+, I-E) with DBA/2J mice (MMTV7+,
MMTV8+, I-E+). C57Bl/6 mice have populations of Vb6+ and
Vb11+ SP thymocytes (6.43 and 4.32% of SP, respectively),
but in I-E+ DBA/2J 3 C57Bl/6 F1 mice, these populations are
deleted by vSAG7 and 8 (Fig. 5A). The p110ABD transgene did
not rescue the development of these populations in DBA/2J 3
C57Bl/6 F1 mice.
SAG-mediated deletion is an extremely stringent form of
negative selection, however. If p110ABD exerts a subtle affect
upon the signaling thresholds for selection, this effect could be
obscured in this system. We therefore utilized an in vitro
technique that allows dose-response analysis of antigen-
mediated deletion of thymocytes expressing the Tg TCR OT-I.
The OT-I TCR recognizes an ovalbumin peptide (SIINFEKL)
in the context of the MHC class I molecule H-2Kb (23). The co-
culture of OT-I thymocytes with APCs presenting SIINFEKL
provides an in vitro model for negative selection that is dose
dependent (9). OT-I and OT-I p110ABD thymocytes were
cultured with APC loaded with different concentrations of
SIINFEKL and analyzed after 18 h. DP thymocytes from both
OT-I and OT-I p110ABD were efficiently deleted in a dose-
dependent fashion, with an LD50 of 10
10 M peptide. In
individual experiments, there appeared to be slight increases
in OT-I/p110ABD DP thymocyte survival relative to OT-I thy-
mocytes at high peptide concentrations. However, statistical
analyses of the data from multiple deletion assays (n = 14),
normalized so that the DP survival rate was expressed as
a percentage of the survival in the absence of peptide, showed
that the difference was not significant (Fig. 5B). This result
confirmed the failure of p110ABD to alter negative selection.
Discussion
Class IA PI3Ks are involved in the regulation of mature T and
B cell function (24, 25). Studies using PI3K knockout mice
have demonstrated that alterations in both the adaptor (p85a,
p55a, p50a) (6, 20) and the catalytic (p110d) subunits of PI3K
(19) profoundly inhibit B cell development. However, these
studies did not reveal any defects in T cell development. PI3K
subunit redundancy, suggested by the residual PI3K activity
observed in T cells in some of these knockout mice, may
account for these results.
Fig. 5. Negative selection is unaffected by p110ABD expression in vitro
and in vivo. (A) The p110ABD transgene does not protect thymocytes
from stringent, SAG-mediated negative selection. p110ABD mice
(endogenously infected with MMTV8 but lacking I-E) were crossed
with DBA/2J mice (MMTV7+ I-E+). In the F1 progeny, SAGs 7 and 8
cross-link I-E molecules to TCR Vb6 and Vb11, respectively, efficiently
inducing deletion of all thymocytes bearing these TCR segments.
Expression of p110ABD is not sufficient to rescue the development of
these thymocytes in F1 mice. (B) OT-I and OT-I/p110ABD DP thy-
mocytes survive the same in an in vitro deletion assay. The p110ABD
transgene was crossed onto the OT-I transgenic line expressing a TCR
specific for the SIINFEKL peptide, and thymocytes were co-cultured
for 18 h with APCs and varying doses of peptide. DP thymocytes will
undergo antigen-dependent apoptosis with a frequency related to the
concentration of peptide. We find that although OT-I p110ABD DP may
survive slightly better than OT-I at high concentrations of peptide, the
improvement is not significant when the data from multiple experi-
ments are combined. The graph includes data from eight independent
experiments, each performed in duplicate (n¼ 14 for each genotype).
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We have used an alternative approach, transgenic expres-
sion of a gain-of-function mutant (p110ABD) in thymocytes,
to analyze the role of PI3K at the transition between immature
DP and mature SP thymocytes. This system allows for the
modification of the pathway exclusively in developing thymo-
cytes, which may be important given that PI3K activity affects
the survival and function of APCs (26–28). We have previously
shown (7) that p110ABD co-immunoprecipitates p85 and
decreases the level of endogenous p110a (suggesting
a shorter protein half-life). A fraction of the endogenous full-
length p110a, and perhaps other p110 isoforms, are present
as catalytically active monomers in resting p110ABD thymo-
cytes. The constitutive activation of Akt in resting p110ABD
thymocytes agrees with this interpretation. Furthermore, the
activation levels achieved with our construct are comparable
to those induced in normal thymocytes by triggering of the
TCR–CD3 complex.
Expression of p110ABD results in an increase in the
percentage and total numbers of mature SP T cells in the
thymus, clearly indicating that the levels of activity of PI3K can
affect T cell development. This phenotype is in part due to
alterations in thymic exit in p110ABD mice (7), although other
processes may also contribute to it: PI3K could improve DP
survival, making it easier for the developing cells to express
a good TCR and be positively selected; it could improve
positively selecting signals, rescuing cells whose TCR react
with very low affinity with self-MHC+ peptide or it could inhibit
negative selection, allowing cells that would normally be
deleted to mature.
An enhancement in survival would be consistent with the role
of PI3K in many different systems. The PI3K downstream
effector Akt improves survival by phosphorylating the pro-
apoptotic Bcl-2 family member Bad and inhibiting its associ-
ation with Bcl-XL, the anti-apoptotic Bcl-2 family member that
mediates DP survival (29, 30) It can also increase NF-jB
activity (31), another pathway important for survival. Over-
expression of Bad in thymocytes greatly reduces the total
number of thymocytes and the percentages of SP thymocytes
(12), and expression of a constitutively active Akt in thymo-
cytes improves their survival (10). However, in spite of elevated
Akt activity, we did not find changes in Bad phosphorylation or
Bcl-XL levels in p110ABD thymocytes. Also p110ABD thymocytes
did not exhibit increased NF-jB DNA-binding activity com-
pared with NLC. These results explain the lack of effect of
p110ABD on thymocyte survival, although we do not yet under-
stand the compensatory mechanisms that mediate the regu-
lation of Bad and NF-jB in these cells. However, DP survival
was likewise unaffected by the expression of the activating
transgene p65PI3K, in agreement with our results (13).
The increased number of mature T cells in the thymus of
p110ABD mice could also be due to improved positive
selection. To test this we analyzed positive selection of the
AND Tg TCR in a weakly selecting background (H-2b/d). This
system has been used in the past to confirm the role of MAPK
in positive selection (14). Our results show that expression of
p110ABD dramatically improved selection in the H-2
b/d back-
ground to the levels observed in an optimal selecting back-
ground, H-2
b/b
. We observed no skewing in CD4/CD8 ratios in
our p110ABD animals, by comparison, or appearance of ma-
ture CD4 SP bearing class I-restricted TCRs in OT-I/p110ABD
animals or in female p110ABD mice expressing the class I-
restricted Tg TCR HY (data not shown). This contrasts with
recent results that showed appearance of some CD4 SP cells
in class I-restricted TCR backgrounds in mice over-expressing
p65PI3K (13). Whether this difference is due to the levels of
p110 activity or to the use of different class I-restricted TCR
strains remains to be determined. By contrast with the positive
selection enhancement, we were unable to detect any effects
of p110ABD on negative selection, either in vivo (using a SAG
model or in HY TCR male mice) or using a peptide-induced
in vitro deletion assay in OT-I mice.
A number of different signaling pathways transduce select-
ing signals from the TCR to the nucleus and, among them,
PI3K activity can regulate activation of the Ras/MAPK pathway
and calcium mobilization (24, 25). We directly tested whether
expression of p110ABD would affect MAPK activation and
calcium mobilization in DP thymocytes. Our results show that
p110ABD does not alter the induction of two downstream
targets of MAPK, the surface glycoprotein CD69 (21) and the
transcription factor Egr (32). Neither their kinetics nor their
levels of expression in response to different doses of anti-CD3
antibodies were affected in the presence of p110ABD. This
suggests that the increased efficiency in positive selection in
p110ABD transgenic mice is independent of effects on MAPK.
In contrast, expression of p110ABD increased the ability of DP
thymocytes to flux Ca++ in response to low doses of anti-CD3
(7). The maximal response was not increased, suggesting that
the effect of the transgene in vivo is more relevant for low
affinity TCR–MHC interactions, those that result in positive
selection, than for the higher affinity interactions involved in
negative selection. Since Ca++-dependent events, such as
transcription of the Nur-77 family of transcription factors (1),
are critical for negative selection, the lack of effect of p110ABD
may be due to a selective role for PI3K in regulating Ca++ in
response to low intensity stimuli. Although it is possible that the
systems we used to determine effects on negative selection
are not sensitive enough to detect subtle differences, or that
the OT-I in vitro deletion cultures do not completely mimic
negative selection in vivo, over-expression in the thymus of low
levels of constitutively active calcineurin, a calcium-regulated
phosphatase that regulates expression of Nur77 (3, 4), results
in improved positive selection without alterations in negative
selection (2). Therefore, subtle alteration in Ca++ responses
may have a bigger impact on positive selection.
In B cells, PI3K plays a crucial role in the regulation of Btk,
a Tec family kinase, by recruiting it to the membrane where it is
activated. Activated Btk in turn contributes to PLC-c activation,
leading to increases in intracellular calcium levels (25). In fact,
disruptions of the p85a adaptor gene phenocopy the XLA/xid
mutants and the Btk/ mice (6). Thymocytes express high
levels of two members of the Tec family of tyrosine kinases (Itk
and Rlk) and very low levels of Tec (33). Positive selection
is impaired in Itk/ animals and completely disrupted in
Itk/Rlk/ animals (33, 34). Negative selection is appar-
ently normal in Itk null mice but is inhibited in mice deficient for
both Itk and Rlk. It remains to be determined whether these
effects are due to alterations in calcium responses or to other
downstream effectors of Tec kinases (35).
T cells deficient in Tec kinases have alterations in PLC-c
activity and calcium mobilization (36). Thus, during T cell
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development, PI3K may contribute to the modulation of
intracellular calcium levels by regulating the activation of Tec
kinases. Since Rlk lacks the PH domains required for
membrane localization mediated by PI3K metabolites (37),
Itk is likely to mediate Tec family functions in thymocytes
downstream of PI3K. Genetic experiments to test the role of
PI3K in regulating Itk are currently being pursued. In
agreement with our results presented here, recent studies
in the Itk null background observed inhibition of positive selec-
tion without alteration of CD4/CD8 lineage commitment (38).
Our results show that during T cell development, PI3K
contributes to the regulation of intracellular calcium levels in
response to low levels of TCR stimulation and improves the
efficiency of positive selection without affecting negative
selection or survival. These results, together with experiments
in the B cell system where PI3K-mediates activation of Btk
which in turn potentiates calcium fluxes, suggest that PI3K
could play a role in the regulation of Tec kinases in Tcells, and
that during development B and T cells share a common
signaling network to modulate intracellular calcium levels in
response to low intensity signals from their antigen receptor.
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APC antigen-presenting cell
BrdU 5-bromo-2-deoxyuridine
DN double negative
DP double positive
ME mercaptoethanol
MMTV mouse mammary tumor virus
NF-jB nuclear factor-jB
NIH National Institutes of Health
PH pleckstrin homology
PI3K phosphatidylinositol 3-kinase
SP single positive
Tg TCR transgenic TCR
vSAG viral superantigen
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